Enamine

Enamine

Private
KyivHealthcare & Life Scienceshttps://enamine.net/

Last Round

Grant

Apr 1, 2023

Total Funding Raised

$3.17M

Company Overview

Enamine is a chemical research company that provides screening compounds, building blocks, fragments, and a range of research and development services for the pharmaceutical, biotech, and other research organizations.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

contract research organizationCROchemical compoundsdrug discovery servicesbuilding blocksscreening compoundsmake-on-demand synthesiscustom synthesissmall molecule libraryintegrated drug discoveryREAL spacevirtual screening librarychemical spacepharma supply chainfragment-based drug discoverycomputer-aided drug designCADDbiology servicesADME/TAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enamine Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Enamine Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantApr 1, 2023
GrantDec 9, 2020
GrantJan 1, 2016

Enamine Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2023

    $108K grant awarded by the European Union.

  • Dec 9, 2020

    Secured $2.3M from the European Research Council.

Enamine Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Enamine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Enamine's valuation, stock price, and market status.

Firmographic Details

HeadquartersKyiv
Year Founded1991
Last FundingApr 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.